At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
In Brief
A Phase 4 clinical trial evaluating levothyroxine sodium capsule, Proton pump inhibitor (PPI), and 1 other intervention for Hypothyroidism;Postablative. Completed, enrolled 66 participants across 9 sites.
Detailed Summary
This is an open-label therapeutic efficacy study of Tirosint (levothyroxine sodium) capsules in thyroidectomized patients taking proton pump inhibitors and levothyroxine, evaluating changes in serum levels of Thyroid Stimulating Hormone (TSH) upon switch to Tirosint with respect to baseline.
Study Details
Timeline
Interventions
after the run-in period, patients will be switched to levothyroxine sodium capsule at the same dose used during run-in
for the whole study duration all subjects will keep taking their proton pump inhibitor medication, as per prescription and as before inclusion
during the run-in period, subjects will continue taking their levothyroxine sodium tablet medication as per prescription and as before inclusion